FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136102721> ?p ?o ?g. }

• W3136102721 endingPage "1634" @default.
• W3136102721 startingPage "1623" @default.
• W3136102721 abstract "Bacterial infections caused by multi-drug-resistant Gram-negative pathogens pose a serious threat to public health. Gram-negative bacteria are characterized by the enrichment of lipid A-anchored lipopolysaccharide (LPS) or lipooligosaccharide (LOS) in the outer leaflet of their outer membrane. Constitutive biosynthesis of lipid A via the Raetz pathway is essential for bacterial viability and fitness in the human host. The inhibition of early-stage lipid A enzymes such as LpxC not only suppresses the growth of Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter spp., and other clinically important Gram-negative pathogens but also sensitizes these bacteria to other antibiotics. The inhibition of late-stage lipid A enzymes such as LpxH is uniquely advantageous because it has an extra mechanism of bacterial killing through the accumulation of toxic lipid A intermediates, rendering LpxH inhibition additionally lethal to Acinetobacter baumannii. Because essential enzymes of the Raetz pathway have never been exploited by commercial antibiotics, they are excellent targets for the development of novel antibiotics against multi-drug-resistant Gram-negative infections.This Account describes the ongoing research on characterizing the structure and inhibition of LpxC and LpxH, the second and fourth enzymes of the Raetz pathway of lipid A biosynthesis, in the laboratories of Dr. Pei Zhou and Dr. Jiyong Hong at Duke University. Our studies have elucidated the molecular basis of LpxC inhibition by the first broad-spectrum inhibitor, CHIR-090, as well as the mechanism underlying its spectrum of activity. Such an analysis has provided a molecular explanation for the broad-spectrum antibiotic activity of diacetylene-based LpxC inhibitors. Through the structural and biochemical investigation of LpxC inhibition by diacetylene LpxC inhibitors and the first nanomolar LpxC inhibitor, L-161,240, we have elucidated the intrinsic conformational and dynamics difference in individual LpxC enzymes near the active site. A similar approach has been taken to investigate LpxH inhibition, leading to the establishment of the pharmacophore model of LpxH inhibitors and subsequent structural elucidation of LpxH in complex with its first reported small-molecule inhibitor based on a sulfonyl piperazine scaffold.Intriguingly, although our crystallographic analysis of LpxC- and LpxH-inhibitor complexes detected only a single inhibitor conformation in the crystal lattice, solution NMR studies revealed the existence of multiple ligand conformations that together delineate a cryptic ligand envelope expanding the ligand-binding footprint beyond that observed in the crystal structure. By harnessing the ligand dynamics information and structural insights, we demonstrate the feasibility to design potent LpxC and LpxH inhibitors by merging multiple ligand conformations. Such an approach has enabled us to rationally design compounds with significantly enhanced potency in enzymatic assays and outstanding antibiotic activities in vitro and in animal models of bacterial infection. We anticipate that continued efforts with structure and ligand dynamics-based lead optimization will ultimately lead to the discovery of LpxC- and LpxH-targeting clinical antibiotics against a broad range of Gram-negative pathogens." @default.
• W3136102721 created "2021-03-29" @default.
• W3136102721 creator A5003416661 @default.
• W3136102721 creator A5016607961 @default.
• W3136102721 date "2021-03-15" @default.
• W3136102721 modified "2023-10-16" @default.
• W3136102721 title "Structure- and Ligand-Dynamics-Based Design of Novel Antibiotics Targeting Lipid A Enzymes LpxC and LpxH in Gram-Negative Bacteria" @default.
• W3136102721 cites W1499693169 @default.
• W3136102721 cites W1544239338 @default.
• W3136102721 cites W1552673156 @default.
• W3136102721 cites W1580202151 @default.
• W3136102721 cites W1602557976 @default.
• W3136102721 cites W1820763871 @default.
• W3136102721 cites W1870751491 @default.
• W3136102721 cites W1969886816 @default.
• W3136102721 cites W1982788622 @default.
• W3136102721 cites W1989154905 @default.
• W3136102721 cites W1991564172 @default.
• W3136102721 cites W2017800476 @default.
• W3136102721 cites W2018385789 @default.
• W3136102721 cites W2027416207 @default.
• W3136102721 cites W2047575295 @default.
• W3136102721 cites W2048998770 @default.
• W3136102721 cites W2054762986 @default.
• W3136102721 cites W2055364868 @default.
• W3136102721 cites W2056915679 @default.
• W3136102721 cites W2068078902 @default.
• W3136102721 cites W2068143425 @default.
• W3136102721 cites W2089961596 @default.
• W3136102721 cites W2094228352 @default.
• W3136102721 cites W2098997185 @default.
• W3136102721 cites W2102150398 @default.
• W3136102721 cites W2104367605 @default.
• W3136102721 cites W2105838577 @default.
• W3136102721 cites W2109824815 @default.
• W3136102721 cites W2115486016 @default.
• W3136102721 cites W2123854432 @default.
• W3136102721 cites W2126265318 @default.
• W3136102721 cites W2134141380 @default.
• W3136102721 cites W2142909774 @default.
• W3136102721 cites W2145952139 @default.
• W3136102721 cites W2150260451 @default.
• W3136102721 cites W2150452177 @default.
• W3136102721 cites W2165473666 @default.
• W3136102721 cites W2171780940 @default.
• W3136102721 cites W2179036997 @default.
• W3136102721 cites W2296140671 @default.
• W3136102721 cites W2303240441 @default.
• W3136102721 cites W2402130561 @default.
• W3136102721 cites W2470963007 @default.
• W3136102721 cites W2512451507 @default.
• W3136102721 cites W2516742430 @default.
• W3136102721 cites W2517899647 @default.
• W3136102721 cites W2559798858 @default.
• W3136102721 cites W2737166234 @default.
• W3136102721 cites W2737184052 @default.
• W3136102721 cites W2738250517 @default.
• W3136102721 cites W2770937934 @default.
• W3136102721 cites W2789500779 @default.
• W3136102721 cites W2795522764 @default.
• W3136102721 cites W2914975712 @default.
• W3136102721 cites W2959149559 @default.
• W3136102721 cites W2967003857 @default.
• W3136102721 cites W2978689014 @default.
• W3136102721 cites W2982659537 @default.
• W3136102721 cites W3004711518 @default.
• W3136102721 cites W3006688305 @default.
• W3136102721 cites W3040112143 @default.
• W3136102721 cites W3048032171 @default.
• W3136102721 cites W3099965403 @default.
• W3136102721 cites W3116314579 @default.
• W3136102721 cites W4234317413 @default.
• W3136102721 cites W4239755150 @default.
• W3136102721 cites W4255231775 @default.
• W3136102721 doi "https://doi.org/10.1021/acs.accounts.0c00880" @default.
• W3136102721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33720682" @default.
• W3136102721 hasPublicationYear "2021" @default.
• W3136102721 type Work @default.
• W3136102721 sameAs 3136102721 @default.
• W3136102721 citedByCount "11" @default.
• W3136102721 countsByYear W31361027212021 @default.
• W3136102721 countsByYear W31361027212022 @default.
• W3136102721 countsByYear W31361027212023 @default.
• W3136102721 crossrefType "journal-article" @default.
• W3136102721 hasAuthorship W3136102721A5003416661 @default.
• W3136102721 hasAuthorship W3136102721A5016607961 @default.
• W3136102721 hasBestOaLocation W31361027212 @default.
• W3136102721 hasConcept C104317684 @default.
• W3136102721 hasConcept C144464004 @default.
• W3136102721 hasConcept C146587185 @default.
• W3136102721 hasConcept C181199279 @default.
• W3136102721 hasConcept C203014093 @default.
• W3136102721 hasConcept C2776051709 @default.
• W3136102721 hasConcept C2776315533 @default.
• W3136102721 hasConcept C2777637488 @default.
• W3136102721 hasConcept C2778754761 @default.
• W3136102721 hasConcept C2778983983 @default.
• W3136102721 hasConcept C2780183148 @default.

• next